Experts from the American Society for Radiation Oncology (ASTRO) and the National Coalition for Cancer Survivorship (NCCS) will discuss the impact of the COVID-19 pandemic on cancer diagnoses and care during a virtual media briefing on Tuesday, March 30, 2021,…
Early detection helps improve patient outcomes, but data shows that many cancers are going undiagnosed or untreated because of COVID-19.
Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
While decades of research have resulted in substantial improvements in surviving cancer, a key challenge remains in identifying new drugs that improve outcomes for patients. In APL Bioengineering, researchers suggest a major hurdle is the paucity of models for cancer research that accurately represent patient tumors. They provide a perspective on strategies using models from individual patients and where the field needs to go in terms of research in animal systems and in culture systems.
Until you or a loved one are facing treatment for a cancer diagnosis, you may not realize the cost associated with treatment and doctor visits.
SUMMARY Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin and Herceptin. In a Policy Review in The Lancet Oncology, Y. Tony Yang, a professor at the George Washington University…
Andrew M. Evens, the associate director for clinical services and director of the lymphoma program at Rutgers Cancer Institute and the medical director of oncology services at RWJBarnabas Health, discusses the impact of the COVID-19 pandemic on cancer care.
The tools will help doctors and patients make better-informed treatment decisions, enhance the care of brain metastases, and enable hospitals to improve the coordination and effectiveness of their interdisciplinary treatment programs.
Studies have long reported that Black cancer patients have poorer outcomes than their white counterparts.
Rutgers Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center, a designation reserved for those cancer centers who meet the highest of standards in research, treatment, prevention and education. Rutgers Cancer Institute expert explains why this distinction sets Rutgers Cancer Institute and RWJBarnabas Health apart.
A team of researchers interviewed physicians and patients at the beginning of the COVID-19 pandemic to identify eight scenarios impacting cancer care. Using communication strategies, they created examples of language to help oncologists respond to patients empathetically.
Researchers observe significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.
Seattle Cancer Care Alliance (SCCA) announced that Paula Rosput Reynolds will become chair of its Board of Directors. Reynolds takes the helm of the SCCA board from Karen Glover, who served as chair since 2018.
Seattle Cancer Care Alliance (SCCA) announced the beginning of construction on its South Lake Union (SLU) campus to add a new six-story, 150,000 square-foot outpatient cancer treatment clinic.
Minimizing your exposure to COVID-19 doesn’t require sacrificing cancer care or preventive services. Rutgers Cancer Institute of New Jersey and RWJBarnabas Health are taking extra precautions to ensure that patients can continue to receive exceptional care close to home.
For Erika Maestas, MD, the journey to UNM Cancer Center is a journey home. Maestas grew up in Albuquerque, while her parents hailed from rural northern New Mexico. She likes that the UNM Cancer Center’s cutting edge research into cancer treatments gives her a chance to continue learning while continuing to do what she loves: working with patients
The National Comprehensive Cancer Network (NCCN) has published a curated list of high-impact measures for assessing quality improvements in cancer care. The recommendations reflect a landscape analysis from leading oncology experts in order to move the needle on cancer care standards in America.
Cancer care providers will gather in Orlando on March 20-22 for the National Comprehensive Cancer Network® (NCCN®) 2020 Annual Conference: Celebrating 25 Years of NCCN. The three-day, in-person conference features more than 30 educational sessions on state-of-the-art practices in cancer care.
Baylor Scott & White Health’s Glenda Tanner Vasicek Cancer Treatment Center (VCTC) – Temple announces construction of a new radiation oncology facility that will benefit Central Texas patients being treated for cancer. With new radiation treatment equipment and more room for procedures, the facility will be able to treat up to 70 patients per day.
Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.
Looking to the future, radiologists at Mayo Clinic in Rochester saw an opportunity to bring several disparate tools together into a unified space to serve complementary roles in sophisticated, minimally invasive cancer treatments.
Reaffirming its commitment to continued growth and excellence, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health welcome Carolyn Hayes, PhD, RN, NEA-BC, as the new Chief Nursing Officer, RWJBarnabas, Oncology Services and Rutgers Cancer Institute.